ABSTRACT
Understanding development and maintenance of beige adipocytes provide exciting insights in establishing novel therapies against obesity and obesity-associated disorders. Lysine-specific demethylase 1 (Lsd1) is an epigenetic eraser required for differentiation and function of adipocytes. Lsd1 is involved in early commitment of preadipocytes, but dispensable for terminal differentiation of white adipose tissue (WAT). In mature adipocytes, Lsd1 responds to different environmental stimuli to alter metabolic function and enable proper thermogenic and oxidative response. Exposure to cold leads to Lsd1 upregulation and subsequent beiging of WAT. Oppositely, Lsd1 levels decline during aging resulting in a conversion of beige into white adipocytes, associated with loss of thermogenic properties of WAT. Lsd1 maintains beige adipocytes by controlling the expression of the nuclear receptor peroxisome proliferator-activated receptor α. In summary, our studies not only provided insights into the mechanism of age-related beige-to-white adipocyte transition, but also established Lsd1 as a sensor that enables thermogenic response in WAT.
KEYWORDS: aging, beige adipocyte, cold, Lsd1, Ppara
Introduction
Adipose tissue is an important regulator of energy balance and nutritional homeostasis.1 White adipose tissue (WAT) is composed of white adipocytes that store excess triglycerides as large lipid droplets2 and hydrolyze them upon high energy demand.3 In addition to classical white adipocytes, WAT also contains thermogenically active beige adipocytes.4 These cells are characterized by abundance of mitochondria, multilocular lipid droplets, and specific expression of uncoupling protein 1 (Ucp1)5 that converts chemical energy into heat. Due to their capacity to counteract metabolic diseases including obesity and type 2 diabetes, beige adipocytes have recently been recognized as potential therapeutic targets. The number of beige adipocytes in murine WAT varies with anatomic location of the fat depots or with age.6,7 For instance, inguinal WAT (ingWAT) of young mice contains larger proportion of beige adipocytes than what is observed for epididymal WAT (epWAT).8,9 Beige adipocyte appearance can be induced by adrenergic stimulation or exposure to cold,6 whereas their number declines upon high-caloric diet or low physical activity.10,11 With age, Ucp1-positive beige adipocytes are progressively lost from WAT depots and converted into white fat cells.7 Despite the high interest in understanding beige adipocyte development and maintenance, the molecular mechanisms orchestrating emergence and age-related beige-to-white adipocyte transition remain unknown.
Lysine-specific demethylase 1 (Lsd1) is an epigenetic modifier that selectively removes mono- and dimethyl groups from lysine 4 and 9 of histone H3 (H3K4 and H3K9, respectively), thereby causing either repression or activation of gene transcription.12,13 Lsd1 plays a role in early embryonic development and differentiation of various cell types, such as neuronal stem cells,14 myocytes,15 and hematopoietic progenitors.16 A study by Musri et al. suggested that Lsd1 is involved in adipogenesis, since its knock-down impairs differentiation of 3T3-L1 preadipocytes.17 These initial findings prompted us to develop adipocyte-specific mouse models to investigate the role of Lsd1 in WAT development, metabolism, and maintenance.
Lsd1, an early effector of preadipocyte commitment
Adipogenesis requires a sequential activation and repression of genes regulated by pro-adipogenic (e.g. Cebps, Fabp4, Pparγ) and anti-adipogenic (e.g., Gata2) factors. To investigate the involvement of Lsd1 in adipogenesis, we ablated Lsd1 at different time points during mouse development or in vitro differentiation. First, to induce Lsd1 ablation in adipocyte precursors18 we used the Fatty acid binding protein 4 (Fabp4)-Cre deleter strain. Fabp4 expression indeed marks a population of adipocyte progenitors in white and brown adipose tissue,18 but it is also expressed in other cell types including mature adipocytes and endothelial cells.19 We demonstrated that Lsd1 is essential for the development of both white and beige adipocytes, since Lsd1 knockout mice were completely devoid of visceral and subcutaneous fat.20 These data were corroborated by in vitro differentiation of primary preadipocytes isolated from the stromal vascular fraction of various fat depots. In these cells, Lsd1 ablation before adipogenic induction abolished formation of mature adipocytes and strongly downregulated the expression of pro-adipogenic transcription factors Cebpβ, Fabp4, Pparγ, and Cebpα, as well as markers of mature adipocytes Adipoq, Agt, and Rtn.20 The control of early adipogenesis was dependent on Lsd1 demethylase activity, since treatment with Lsd1-specific inhibitor faithfully recapitulated the phenotype observed in knockout cells.20 Our findings are in full agreement with Musri et al. who showed that in 3T3-L1 cells Lsd1 demethylates H3K9me2 histone mark at the Cebpα promoter to activate gene transcription (Fig. 1).
Figure 1.

Lsd1 promotes early adipogenesis in WAT but is dispensable for terminal differentiation. During early adipogenesis and commitment of preadipocytes, Lsd1 enzymatic activity plays an essential role in activating the expression of key adipogenic genes through H3K9me2 demethylation at their promoters. However, Lsd1 is not required during maturation of committed adipocytes.
Although Lsd1 plays a role in early adipogenesis, it is dispensable for maturation of adipocytes at later stages of differentiation. Indeed, our data showed that Lsd1 ablation or inhibition 3 d after induction of differentiation did not affect formation of adipocytes in tissue culture.20 Similar results were obtained by using Adipoq-Cre deleter strain to ablate Lsd1 in differentiating adipocytes. At this developmental stage, Lsd1 ablation did not affect WAT development.21 Together, our data demonstrated that the epigenetic modifier Lsd1 is required for early commitment of preadipocytes. Maturation of adipocytes is not dependent on Lsd1, most probably due to the fact that induced adipocyte-specific transcription factors are sufficient to accomplish terminal differentiation (Fig. 1).
Lsd1 governs the induction of beige adipocytes
Since we found that Lsd1 was involved in WAT development, we questioned whether it would also contribute to the induction of thermogenic beige adipocytes upon cold or β3-adrenergic stimulation. Interestingly, Lsd1 protein levels were increased in ing- and epWAT of wild-type mice after cold exposure or treatment with the β3-adrenergic agonist CL316,243,20 indicating that Lsd1 might mediate thermogenic response in WAT (Fig. 2). To further investigate these findings, we generated mice with adipocyte-specific Lsd1 ablation using inducible Cre recombinase under the control of Adipoq promotor (Adipoq-CreERT2).22 We found that in the absence of Lsd1, ingWAT failed to induce beige adipocytes upon cold stimulation, supporting our hypothesis that Lsd1 mediates thermogenic response in mice.21
Figure 2.

Lsd1 acts as a sensor that integrates different environmental stimuli to enable proper thermogenic and oxidative responses of beige adipocytes. In young mice, physiologic levels of Lsd1 maintain thermogenic properties in WAT. However, with age, Lsd1 levels progressively decline concomitant with beige-to-white adipocytes transition. In WAT, Lsd1 levels can be modulated by different environmental inputs. Cold induces Lsd1 expression together with thermogenic response in WAT, whereas food excess leads to decreased Lsd1 protein levels and to accelerated beige-to-white adipocytes transition.
Opposite from what was observed upon Lsd1 ablation, in transgenic Lsd1 overexpressing mice, elevated Lsd1 levels were sufficient to mimic thermogenic response in the absence of cold stimulus.20 Indeed, these mice displayed a range of morphologic and metabolic phenotypes in WAT associated with an increased number of multilocular mitochondria-rich beige adipocytes expressing high levels of thermogenic (Prdm16, Pgc-1α, Ucp1, Ucp2, and Ucp3) and oxidative markers (Nrf1, Cpt1β, and Cox8b). Due to increased thermogenic and uncoupling capacities, transgenic mice exhibited higher body temperature compared with their control littermates, which limited their weight gain and adiposity of WAT depots upon high-fat diet. In addition, these mice were characterized by decreased blood glucose levels, improved glucose tolerance, and increased insulin sensitivity, indicating decreased propensity to develop type-2 diabetes.20 In conclusion, elevated Lsd1 levels in mice mimic the effects of cold exposure or β3-adrenergic treatment to promote thermogenic and oxidative capacities of WAT.
Using genome-wide transcriptome analysis, we showed that Lsd1-mediated metabolic adaptation to cold is governed by increased expression of Tfam, regulator of mitochondrial biogenesis,23 as well as genes encoding the mitochondrial respiratory chain subunits. Lsd1 directly regulates the expression of these genes in cooperation with Nrf1, a key factor controlling mitochondrial biogenesis.24,25 Together, these experiments show that Lsd1 act as a master regulator of cold stimulation in WAT by controlling a broad thermogenic gene network20 (Fig. 3).
Figure 3.

Lsd1 controls beige-selective transcription Pparα and a broad network of metabolic genes to regulate thermogenic properties of WAT. Under physiologic conditions, Lsd1 activates Pparα expression via H3K9me2 demethylation. In addition, in complex with Nrf1, Lsd1 regulates oxidative capacities of WAT. Upon genetic ablation or declined Lsd1 levels caused by age, Pparα expression is disabled, leading to beige-to-white adipocyte transition. On the other hand, increased Lsd1 levels in transgenic mice or via cold or β3-adrenergic stimulation leads to increased expression of OXPHOS and thermogenic genes, and activates beiging of WAT.
Lsd1 prevents loss of beige adipocytes
Since we observed increased Lsd1 protein expression together with beige fat formation in response to cold or β3-adrenergic stimulation, we hypothesized that Lsd1 levels might also be modulated upon decline of beige adipocytes in WAT. Indeed, we observed that whitening of adipogenic depots with age was accompanied by decreased Lsd1 expression in both ep- and ingWAT of aged wild-type mice21 (Fig. 2). We therefore investigated the role of Lsd1 in the regulation of age-related beige-to-white adipocyte transition by using adipocyte specific gain- and loss of function mouse models. We found that Lsd1 overexpression in adipocytes was sufficient to maintain the pool of beige fat cells with age, whereas Lsd1 ablation led to a premature loss of beige adipocytes, with a complete conversion into white adipocyte appearance at only 10 weeks of age.21 Loss of beige adipocytes was not caused by apoptosis, but by beige-to-white transition, as confirmed by tracing the fate of Ucp1-expressing beige adipocytes upon Lsd1 ablation. For this purpose, we generated Lsd1 knockout mice expressing green fluorescent protein (GFP)-diphtheria toxin receptor (Dtr) fusion construct under the control of the Ucp1 promoter (Ucp1-Dtr-GFP reporter strain).26 In such mice, GFP-Dtr protein was selectively addressed to the membrane of Ucp1-positive cells, allowing us to trace beige fat cells even after they adopted white adipocyte morphology. Since unilocular adipocytes in Lsd1-ablated ingWAT expressed GFP, we concluded that Ucp1-expressing beige adipocytes were formed, but rapidly acquired white adipocyte appearance. These findings demonstrated that Lsd1 is required for maintenance of beige adipocytes in WAT.21 Using a similar approach, we showed that Lsd1 is not only responsible for the maintenance of endogenous / basal beige adipocytes, but also for conserving the pool of cold-induced beige adipocytes. Ablation of Lsd1 after 10 d of cold-treatment rendered the mice incapable of maintaining beige adipocytes, and their ingWAT displayed a white adipocyte morphology devoid of thermogenic abilities even in conditions of continued cold stimulus.21
Next, we questioned the molecular mechanism through which Lsd1 allows the maintenance of beige adipocytes. Our transcriptome analysis in Lsd1-ablated ingWAT revealed the importance of the Peroxisome proliferator-activated receptor (Ppar) signaling pathway in Lsd1-mediated maintenance of beige adipocytes in WAT.21 Ppars are ligand-regulated nuclear receptors that play important roles in fat differentiation and metabolism.27,28 In particular, Pparα seems to be more brown-specific, since it is expressed at higher levels in brown relative to white adipocytes.29,30 Since beige adipocytes share common metabolic features with brown adipocytes, we hypothesized that Pparα might contribute to the maintenance of beige adipocytes. Indeed, Pparα transcript levels were decreased upon loss of Lsd1 in ingWAT, indicating that Lsd1 is regulating Pparα expression. A detailed analysis of the Pparα locus by chromatin immunoprecipitation revealed that Lsd1 directly activates Pparα expression since Lsd1 was bound to the Pparα promoter together with p300 and PolII, leading to decrease in H3K9me2 levels (Fig. 3). In accordance, Pparα levels in WAT strongly decreased with age, similar to Lsd1. These observations are in accordance with literature data showing that Pparα-null mice display reduced number of beige adipocytes.31 Using pharmacological Pparα agonist32 and antagonist,33,34 we confirmed that Pparα mediates the effects of Lsd1 in maintaining beige adipocytes. Treatment of young Lsd1 knockout mice with Pparα agonist was sufficient to alleviate the premature beige-to-white adipocyte transition and to restore the transcript levels of beige fat markers. Oppositely, pharmacological inhibition of Pparα action in aged Lsd1 overexpressing mice abrogated maintenance of beige adipocytes.21 These findings are of particular interest, since they indicate that pharmacological modulation of Pparα signaling can be used as a therapeutic strategy to maintain beige adipose tissue during aging and preserve lean phenotype in mice.
Conclusion
Our work underlines important roles of Lsd1 in different aspects of WAT development, maintenance, and function. During early development Lsd1 is essential for the formation of adipose tissue (Fig. 1). In mature adipocytes, Lsd1 acts as a sensor that integrates different environmental stimuli to alter metabolic function and enable proper thermogenic and oxidative responses (Fig. 2). Exposure to cold leads to Lsd1 upregulation and subsequent beiging of WAT, whereas during aging Lsd1 levels decline resulting in a loss of thermogenic properties of WAT (Fig. 3). Our study has for the first time implicated an epigenetic eraser Lsd1 in white adipose tissue metabolism. Further experiments are required to identify how Lsd1 expression levels are regulated by environmental cues and what kind of factors convey information from cell surface to the nucleus. Unraveling mechanisms governing development and maintenance of beige adipocytes provide exciting insights in establishing novel therapies against obesity and obesity-associated disorders.
Disclosure of potential conflicts of interest
No potential conflicts of interest were disclosed.
Funding
This work was supported by grants of the European Research Council (ERC AdGrant 322844 to R.S.) and the Deutsche Forschungsgemeinschaft (SFB 992, 850, 746 to R.S.).
References
- [1].Langin D. Recruitment of brown fat and conversion of white into brown adipocytes: strategies to fight the metabolic complications of obesity? Biochim Biophys Acta 2010; 1801:372-6; PMID:19782764; https://doi.org/ 10.1016/j.bbalip.2009.09.008 [DOI] [PubMed] [Google Scholar]
- [2].Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell 2014; 156; 20-44; PMID:24439368; https://doi.org/ 10.1016/j.cell.2013.12.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Attie AD, Scherer PE. Adipocyte metabolism and obesity. J Lipid Res 2009; 50 Suppl:S395-399; PMID:19017614 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Ishibashi J, Seale P. Medicine. Beige can be slimming. Science 2010; 328:1113-4; PMID:20448151; https://doi.org/ 10.1126/science.1190816 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006; 7:885-96; PMID:17139329; https://doi.org/ 10.1038/nrm2066 [DOI] [PubMed] [Google Scholar]
- [6].Himms-Hagen J, Melnyk A, Zingaretti MC, Ceresi E, Barbatelli G, Cinti S. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am J Physiol Cell Physiol 2000; 279:C670-681; PMID:10942717 [DOI] [PubMed] [Google Scholar]
- [7].Rogers NH, Landa A, Park S, Smith RG. Aging leads to a programmed loss of brown adipocytes in murine subcutaneous white adipose tissue. Aging Cell 2012; 11:1074-83; PMID:23020201; https://doi.org/ 10.1111/acel.12010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Ohno H, Shinoda K, Spiegelman BM, Kajimura S. PPARgamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 2012; 15:395-404; PMID:22405074; https://doi.org/ 10.1016/j.cmet.2012.01.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Vitali A, Murano I, Zingaretti MC, Frontini A, Ricquier D, Cinti S. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J Lipid Res 2012; 53:619-29; PMID:22271685; https://doi.org/ 10.1194/jlr.M018846 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Stanford KI, Middelbeek RJ¸Goodyear LJ. Exercise effects on white adipose tissue: Beiging and metabolic adaptations. Diabetes 2015; 64:2361-8; PMID:26050668; https://doi.org/ 10.2337/db15-0227 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Claycombe KJ, Vomhof-DeKrey EE, Garcia R, Johnson WT, Uthus E, Roemmich JN. Decreased beige adipocyte number and mitochondrial respiration coincide with increased histone methyl transferase (G9a) and reduced FGF21 gene expression in Sprague-Dawley rats fed prenatal low protein and postnatal high-fat diets. J Nutr Biochem 2016; 31:113-21; PMID:27133430; https://doi.org/ 10.1016/j.jnutbio.2016.01.008 [DOI] [PubMed] [Google Scholar]
- [12].Metzger E, Wissmann M, Yin N, Müller JM, Schneider R, Peters AH, Günther T, Buettner R, Schüle R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005; 437:436-9; PMID:16079795 [DOI] [PubMed] [Google Scholar]
- [13].Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119:941-53; PMID:15620353; https://doi.org/ 10.1016/j.cell.2004.12.012 [DOI] [PubMed] [Google Scholar]
- [14].Wang Y, Wu Q, Yang P, Wang C, Liu J, Ding W, Liu W, Bai Y, Yang Y, Wang H, et al.. LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain. Nat Commun 2016; 7:10481; PMID:26795843; https://doi.org/ 10.1038/ncomms10481 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Choi J, Jang H, Kim H, Kim ST, Cho EJ, Youn HD. Histone demethylase LSD1 is required to induce skeletal muscle differentiation by regulating myogenic factors. Biochem Biophys Res Commun 2010; 401:327-32; PMID:20833138; https://doi.org/ 10.1016/j.bbrc.2010.09.014 [DOI] [PubMed] [Google Scholar]
- [16].Sprussel A, Schulte JH, Weber S, Necke M, Händschke K, Thor T, Pajtler KW, Schramm A, König K, Diehl L, et al.. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia 2012; 26:2039-51; PMID:22699452; https://doi.org/ 10.1038/leu.2012.157 [DOI] [PubMed] [Google Scholar]
- [17].Musri MM, Carmona MC, Hanzu FA, Kaliman P, Gomis R, Párrizas M. Histone demethylase LSD1 regulates adipogenesis. J Biol Chem 2010; 285:30034-41; PMID:20656681; https://doi.org/ 10.1074/jbc.M110.151209 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Shan T, Liu W, Kuang S. Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues. FASEB J 2013; 27:277-87; PMID:23047894; https://doi.org/ 10.1096/fj.12-211516 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Berry R, Jeffery E, Rodeheffer MS. Weighing in on adipocyte precursors. Cell Metab 2014; 19:8-20; PMID:24239569; https://doi.org/ 10.1016/j.cmet.2013.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Duteil D, Metzger E, Willmann D, Karagianni P, Friedrichs N, Greschik H, Günther T, Buettner R, Talianidis I, Metzger D, et al.. LSD1 promotes oxidative metabolism of white adipose tissue. Nat Commun 2014; 5:4093; PMID:24912735; https://doi.org/ 10.1038/ncomms5093 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Duteil D, Tosic M, Willmann D, Georgiadi A, Kanouni T, Schüle R. Lsd1 prevents age-programed loss of beige adipocytes. Proc Natl Acad Sci U S A 2017; 114:5265-70; PMID:28461471; https://doi.org/ 10.1073/pnas.1702641114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Sassmann A, Offermanns S, Wettschureck N. Tamoxifen-inducible Cre-mediated recombination in adipocytes. Genesis 2010; 48:618-25; PMID:20715175; https://doi.org/ 10.1002/dvg.20665 [DOI] [PubMed] [Google Scholar]
- [23].Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008; 88:611-38; PMID:18391175; https://doi.org/ 10.1152/physrev.00025.2007 [DOI] [PubMed] [Google Scholar]
- [24].van Tienen FH, Lindsey PJ, van der Kallen CJ, Smeets HJ. Prolonged Nrf1 overexpression triggers adipocyte inflammation and insulin resistance. J Cell Biochem 2010; 111:1575-85; PMID:21053274; https://doi.org/ 10.1002/jcb.22889 [DOI] [PubMed] [Google Scholar]
- [25].Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, Kim SY, Kim MS, Kim SW, Park IS, et al.. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007; 56:2973-81; PMID:17827403; https://doi.org/ 10.2337/db07-0510 [DOI] [PubMed] [Google Scholar]
- [26].Rosenwald M, Perdikari A, Rulicke T, Wolfrum C. Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol 2013; 15:659-67; PMID:23624403; https://doi.org/ 10.1038/ncb2740 [DOI] [PubMed] [Google Scholar]
- [27].Picard F, Géhin M, Annicotte J, Rocchi S, Champy MF, O'Malley BW, Chambon P, Auwerx J. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 2002; 111:931-41; PMID:12507421; https://doi.org/ 10.1016/S0092-8674(02)01169-8 [DOI] [PubMed] [Google Scholar]
- [28].Seale P. Transcriptional regulatory circuits controlling brown fat development and activation. Diabetes 2015; 64:2369-75; PMID:26050669; https://doi.org/ 10.2337/db15-0203 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Rachid TL, Penna-de-Carvalho A, Bringhenti I, Aguila MB, Mandarim-de-Lacerda CA, Souza-Mello V. Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice. Mol Cell Endocrinol 2015; 402:86-94; PMID:25576856; https://doi.org/ 10.1016/j.mce.2014.12.027 [DOI] [PubMed] [Google Scholar]
- [30].Wang L, Teng R, Di L, Rogers H, Wu H, Kopp JB, Noguchi CT. PPARalpha and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes 2013; 62:4122-31; PMID:23990359; https://doi.org/ 10.2337/db13-0518 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Li P, Zhu Z, Lu Y, Granneman JG. Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-alpha. Am J Physiol Endocrinol Metab 2005; 289:E617-626; PMID:15941786; https://doi.org/ 10.1152/ajpendo.00010.2005 [DOI] [PubMed] [Google Scholar]
- [32].Galmozzi A, Sonne SB, Altshuler-Keylin S, Hasegawa Y, Shinoda K, Luijten IH, Chang JW, Sharp LZ, Cravatt BF, Saez E, et al.. ThermoMouse: an in vivo model to identify modulators of UCP1 expression in brown adipose tissue. Cell Rep 2014; 9:1584-93; PMID:25466254; https://doi.org/ 10.1016/j.celrep.2014.10.066 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Guerre-Millo M, Gervois P, Raspé E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, et al.. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 2000; 275:16638-42; PMID:10828060; https://doi.org/ 10.1074/jbc.275.22.16638 [DOI] [PubMed] [Google Scholar]
- [34].Harrington WW, S Britt C, G Wilson J, O Milliken N, G Binz J, C Lobe D, R Oliver W, C Lewis M, M Ignar D. The effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan agonists on body weight, body mass, and serum lipid profiles in diet-induced obese AKR/J mice. PPAR Res 2007; 2007:97125; PMID:17710237; https://doi.org/ 10.1155/2007/97125 [DOI] [PMC free article] [PubMed] [Google Scholar]
